Shixia Wang

ORCID

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 11

Top Venues

Nature communications

Vaccines

PLoS pathogens

Research square

This page only lists publications with an associated author ORCID identifier.

Publications

Shixia Wang, Kun-Wei Chan, Danlan Wei, Xiuwen Ma, Shuying Liu, Guangnan Hu, Saeyoung Park, Ruimin Pan, Ying Gu, Alexandra F Nazzari, Adam S Olia, Kai Xu, Bob C Lin, Mark K Louder, Krisha McKee, Nicole A Doria-Rose, David C Montefiori, Michael S Seaman, Tongqing Zhou, Peter D Kwong, James Arthos, Xiang-Peng Kong, Shan Lu
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains. Nature communications 15 (1) (2024)
Shixia Wang, Kun-Wei Chan, Danlan Wei, Xiuwen Ma, Shuying Liu, Guangnan Hu, Saeyoung Park, Ruimin Pan, Ying Gu, Alexandra F Nazzari, Adam S Olia, Kai Xu, Bob C Lin, Mark K Louder, Krisha McKee, Nicole A Doria-Rose, David C Montefiori, Michael S Seaman, Tongqing Zhou, Peter D Kwong, James Arthos, Xiang-Peng Kong, Shan Lu
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains. Nature communications 15 (1) (2024)
Shixia Wang, Kun-Wei Chan, Danlan Wei, Xiuwen Ma, Shuying Liu, Guangnan Hu, Saeyoung Park, Ruimin Pan, Ying Gu, Alexandra F Nazzari, Adam S Olia, Kai Xu, Bob C Lin, Mark K Louder, Krisha McKee, Nicole A Doria-Rose, David C Montefiori, Michael S Seaman, Tongqing Zhou, Peter D Kwong, James Arthos, Xiang-Peng Kong, Shan Lu
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains. Nature communications 15 (1) (2024)
Shixia Wang, Kun-Wei Chan, Danlan Wei, Xiuwen Ma, Shuying Liu, Guangnan Hu, Saeyoung Park, Ruimin Pan, Ying Gu, Alexandra F Nazzari, Adam S Olia, Kai Xu, Bob C Lin, Mark K Louder, Krisha McKee, Nicole A Doria-Rose, David C Montefiori, Michael S Seaman, Tongqing Zhou, Peter D Kwong, James Arthos, Xiang-Peng Kong, Shan Lu
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains. Nature communications 15 (1) (2024)
Shixia Wang, Kun-Wei Chan, Danlan Wei, Xiuwen Ma, Shuying Liu, Guangnan Hu, Saeyoung Park, Ruimin Pan, Ying Gu, Alexandra F Nazzari, Adam S Olia, Kai Xu, Bob C Lin, Mark K Louder, Krisha McKee, Nicole A Doria-Rose, David C Montefiori, Michael S Seaman, Tongqing Zhou, Peter D Kwong, James Arthos, Xiang-Peng Kong, Shan Lu
Human CD4-binding site antibody elicited by polyvalent DNA prime-protein boost vaccine neutralizes cross-clade tier-2-HIV strains. Nature communications 15 (1) (2024)
Shan Lu, Shixia Wang, Kun-Wei Chan, Danlan Wei, Xiuwen Ma, Shuying Liu, Guangna Hu, Saeyoung Park, Ruimin Pan, Ying Gu, Alexandra Nazzari, Adam Olia, Kai Xu, Bob Lin, Mark K Louder, Nicole A Doria-Rose, David C Montefiori, Michael Seaman, Tongqing Zhou, Peter Kwong, James Arthos, Xiang-Peng Kong
Human CD4-Binding Site Antibody Elicited by Polyvalent DNA Prime-Protein Boost Vaccine Neutralizes Cross-Clade Tier-2-HIV Strains. Research square (2023)
Shixia Wang, Farshad Guirakhoo, Sivakumar Periasamy, Valorie Ryan, Jonathan Wiggins, Chandru Subramani, Brett Thibodeaux, Jaya Sahni, Michael Hellerstein, Natalia A Kuzmina, Alexander Bukreyev, Jean-Cosme Dodart, Alexander Rumyantsev
RBD-Protein/Peptide Vaccine UB-612 Elicits Mucosal and Fc-Mediated Antibody Responses against SARS-CoV-2 in Cynomolgus Macaques. Vaccines 12 (1) (2023)
Shixia Wang, Farshad Guirakhoo, Sivakumar Periasamy, Valorie Ryan, Jonathan Wiggins, Chandru Subramani, Brett Thibodeaux, Jaya Sahni, Michael Hellerstein, Natalia A Kuzmina, Alexander Bukreyev, Jean-Cosme Dodart, Alexander Rumyantsev
RBD-Protein/Peptide Vaccine UB-612 Elicits Mucosal and Fc-Mediated Antibody Responses against SARS-CoV-2 in Cynomolgus Macaques. Vaccines 12 (1) (2023)
Shixia Wang, Farshad Guirakhoo, Sivakumar Periasamy, Valorie Ryan, Jonathan Wiggins, Chandru Subramani, Brett Thibodeaux, Jaya Sahni, Michael Hellerstein, Natalia A Kuzmina, Alexander Bukreyev, Jean-Cosme Dodart, Alexander Rumyantsev
RBD-Protein/Peptide Vaccine UB-612 Elicits Mucosal and Fc-Mediated Antibody Responses against SARS-CoV-2 in Cynomolgus Macaques. Vaccines 12 (1) (2023)
Farshad Guirakhoo, Shixia Wang, Chang Yi Wang, Hui Kai Kuo, Wen Jiun Peng, Hope Liu, Lixia Wang, Marina Johnson, Adam Hunt, Mei Mei Hu, Thomas P Monath, Alexander Rumyantsev, David Goldblatt
High Neutralizing Antibody Levels Against Severe Acute Respiratory Syndrome Coronavirus 2 Omicron BA.1 and BA.2 After UB-612 Vaccine Booster. The Journal of infectious diseases 226 (8) (2022)
Catarina E Hioe, Guangming Li, Xiaomei Liu, Ourania Tsahouridis, Xiuting He, Masaya Funaki, Jéromine Klingler, Alex F Tang, Roya Feyznezhad, Daniel W Heindel, Xiao-Hong Wang, David A Spencer, Guangnan Hu, Namita Satija, Jérémie Prévost, Andrés Finzi, Ann J Hessell, Shixia Wang, Shan Lu, Benjamin K Chen, Susan Zolla-Pazner, Chitra Upadhyay, Raymond Alvarez, Lishan Su
Non-neutralizing antibodies targeting the immunogenic regions of HIV-1 envelope reduce mucosal infection and virus burden in humanized mice. PLoS pathogens 18 (1) (2022)

Shixia Wang.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Shixia Wang